Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias

Besides the diagnostic role in acute myocardial infarction, cardiac troponin I levels (cTNI) may be increased in various other clinical conditions, including heart failure, valvular heart disease and sepsis. However, limited data are available regarding the prognostic role of cTNI in the setting of...

Full description

Bibliographic Details
Main Authors: Ibrahim Akin, Michael Behnes, Julian Müller, Jan Forner, Mohammad Abumayyaleh, Kambis Mashayekhi, Muharrem Akin, Thomas Bertsch, Kathrin Weidner, Jonas Rusnak, Dirk Große Meininghaus, Maximilian Kittel, Tobias Schupp
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/11/2987
_version_ 1797492961106198528
author Ibrahim Akin
Michael Behnes
Julian Müller
Jan Forner
Mohammad Abumayyaleh
Kambis Mashayekhi
Muharrem Akin
Thomas Bertsch
Kathrin Weidner
Jonas Rusnak
Dirk Große Meininghaus
Maximilian Kittel
Tobias Schupp
author_facet Ibrahim Akin
Michael Behnes
Julian Müller
Jan Forner
Mohammad Abumayyaleh
Kambis Mashayekhi
Muharrem Akin
Thomas Bertsch
Kathrin Weidner
Jonas Rusnak
Dirk Große Meininghaus
Maximilian Kittel
Tobias Schupp
author_sort Ibrahim Akin
collection DOAJ
description Besides the diagnostic role in acute myocardial infarction, cardiac troponin I levels (cTNI) may be increased in various other clinical conditions, including heart failure, valvular heart disease and sepsis. However, limited data are available regarding the prognostic role of cTNI in the setting of ventricular tachyarrhythmias. Therefore, the present study sought to assess the prognostic impact of cTNI in patients with ventricular tachyarrhythmias (i.e., ventricular tachycardia (VT) and fibrillation (VF)) on admission. A large retrospective registry was used, including all consecutive patients presenting with ventricular tachyarrhythmias from 2002 to 2015. The prognostic impact of elevated cTNI levels was investigated for 30-day all-cause mortality (i.e., primary endpoint) using Kaplan–Meier, receiver operating characteristic (ROC), multivariable Cox regression analyses and propensity score matching. From a total of 1104 patients with ventricular tachyarrhythmias and available cTNI levels on admission, 46% were admitted with VT and 54% with VF. At 30 days, high cTNI was associated with the primary endpoint (40% vs. 22%; log rank <i>p</i> = 0.001; HR = 2.004; 95% CI 1.603–2.505; <i>p</i> = 0.001), which was still evident after multivariable adjustment and propensity score matching (30% vs. 18%; log rank <i>p</i> = 0.003; HR = 1.729; 95% CI 1.184–2.525; <i>p</i> = 0.005). Significant discrimination of the primary endpoint was especially evident in VT patients (area under the curve (AUC) 0.734; 95% CI 0.645–0.823; <i>p</i> = 0.001). In contrast, secondary endpoints, including all-cause mortality at 30 months and a composite arrhythmic endpoint, were not affected by cTNI levels. The risk of cardiac rehospitalization was lower in patients with high cTNI, which was no longer observed after propensity score matching. In conclusion, high cTNI levels were associated with increased risk of all-cause mortality at 30 days in patients presenting with ventricular tachyarrhythmias.
first_indexed 2024-03-10T01:12:10Z
format Article
id doaj.art-6067ede161624dadbda3a724b640bc96
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T01:12:10Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-6067ede161624dadbda3a724b640bc962023-11-23T14:14:54ZengMDPI AGJournal of Clinical Medicine2077-03832022-05-011111298710.3390/jcm11112987Prognostic Value of Cardiac Troponin I in Patients with Ventricular TachyarrhythmiasIbrahim Akin0Michael Behnes1Julian Müller2Jan Forner3Mohammad Abumayyaleh4Kambis Mashayekhi5Muharrem Akin6Thomas Bertsch7Kathrin Weidner8Jonas Rusnak9Dirk Große Meininghaus10Maximilian Kittel11Tobias Schupp12First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, GermanyFirst Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, GermanyClinic for Interventional Electrophysiology, Heart Centre Bad Neustadt, 97616 Bad Neustadt a. d. Saale, GermanyFirst Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, GermanyFirst Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, GermanyDepartment of Internal Medicine and Cardiology, Mediclin Heart Centre Lahr, 77933 Lahr, GermanyDepartment of Cardiology and Angiology, Hannover Medical School, 30625 Hannover, GermanyInstitute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital, Paracelsus Medical University, 90419 Nuremberg, GermanyFirst Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, GermanyFirst Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, GermanyDepartment of Cardiology, Carl-Thiem-Klinikum Cottbus, 03048 Cottbus, GermanyInstitute for Clinical Chemistry, Faculty of Medicine Mannheim, Heidelberg University, 68167 Mannheim, GermanyFirst Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, GermanyBesides the diagnostic role in acute myocardial infarction, cardiac troponin I levels (cTNI) may be increased in various other clinical conditions, including heart failure, valvular heart disease and sepsis. However, limited data are available regarding the prognostic role of cTNI in the setting of ventricular tachyarrhythmias. Therefore, the present study sought to assess the prognostic impact of cTNI in patients with ventricular tachyarrhythmias (i.e., ventricular tachycardia (VT) and fibrillation (VF)) on admission. A large retrospective registry was used, including all consecutive patients presenting with ventricular tachyarrhythmias from 2002 to 2015. The prognostic impact of elevated cTNI levels was investigated for 30-day all-cause mortality (i.e., primary endpoint) using Kaplan–Meier, receiver operating characteristic (ROC), multivariable Cox regression analyses and propensity score matching. From a total of 1104 patients with ventricular tachyarrhythmias and available cTNI levels on admission, 46% were admitted with VT and 54% with VF. At 30 days, high cTNI was associated with the primary endpoint (40% vs. 22%; log rank <i>p</i> = 0.001; HR = 2.004; 95% CI 1.603–2.505; <i>p</i> = 0.001), which was still evident after multivariable adjustment and propensity score matching (30% vs. 18%; log rank <i>p</i> = 0.003; HR = 1.729; 95% CI 1.184–2.525; <i>p</i> = 0.005). Significant discrimination of the primary endpoint was especially evident in VT patients (area under the curve (AUC) 0.734; 95% CI 0.645–0.823; <i>p</i> = 0.001). In contrast, secondary endpoints, including all-cause mortality at 30 months and a composite arrhythmic endpoint, were not affected by cTNI levels. The risk of cardiac rehospitalization was lower in patients with high cTNI, which was no longer observed after propensity score matching. In conclusion, high cTNI levels were associated with increased risk of all-cause mortality at 30 days in patients presenting with ventricular tachyarrhythmias.https://www.mdpi.com/2077-0383/11/11/2987ventricular tachyarrhythmiascardiac troponin Ibiomarkerssudden cardiac deathcoronary artery disease
spellingShingle Ibrahim Akin
Michael Behnes
Julian Müller
Jan Forner
Mohammad Abumayyaleh
Kambis Mashayekhi
Muharrem Akin
Thomas Bertsch
Kathrin Weidner
Jonas Rusnak
Dirk Große Meininghaus
Maximilian Kittel
Tobias Schupp
Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
Journal of Clinical Medicine
ventricular tachyarrhythmias
cardiac troponin I
biomarkers
sudden cardiac death
coronary artery disease
title Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
title_full Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
title_fullStr Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
title_full_unstemmed Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
title_short Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
title_sort prognostic value of cardiac troponin i in patients with ventricular tachyarrhythmias
topic ventricular tachyarrhythmias
cardiac troponin I
biomarkers
sudden cardiac death
coronary artery disease
url https://www.mdpi.com/2077-0383/11/11/2987
work_keys_str_mv AT ibrahimakin prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT michaelbehnes prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT julianmuller prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT janforner prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT mohammadabumayyaleh prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT kambismashayekhi prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT muharremakin prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT thomasbertsch prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT kathrinweidner prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT jonasrusnak prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT dirkgroßemeininghaus prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT maximiliankittel prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias
AT tobiasschupp prognosticvalueofcardiactroponiniinpatientswithventriculartachyarrhythmias